Similar Search Results

Spotlight on Mycophenolate Mofetil in Solid Organ Transplantation This Spotlight is derived from abstract and summary text of an Adis Pharmacoeconomic Drug Evaluation originally published in full in PharmacoEconomics 2002; 20 (10): 675-713

Young, Melissa; Plosker, Greg L. - In: Disease Management and Health Outcomes 10 (2002) 12, pp. 805-809

Most pharmacoeconomic studies of mycophenolate mofetil have focused on its use as part of maintenance immunosuppression for renal transplantation, involving short-term (3-12 months) time frames. In general, mycophenolate mofetil reduced the treatment costs for rejection episodes and graft...

Persistent link: https://www.econbiz.de/10005404609

Risks and Benefits of the Use of Capitation Formulae in Primary Care

Majeed, Azeem - In: Disease Management and Health Outcomes 10 (2002) 4, pp. 215-220

Increasingly, primary care physicians are being given budgets based on capitation formulae in the belief that such … physicians budgets based on capitation formulae is that governments hope this will lead to beneficial changes in the behavior of … physicians, for example, leading to healthcare resources being used more efficiently and appropriately. Ultimately capitation …

Persistent link: https://www.econbiz.de/10005404610

Health Support of People with Disabilities in South Australia: Innovations in Policy and Practice

Caudrey, David; Dissinger, Marguerite - In: Disease Management and Health Outcomes 15 (2007) 6, pp. 341-353

unnecessary admissions to hospital, enabling children to be included in mainstream education settings, and managing the impact of …

Persistent link: https://www.econbiz.de/10005404611

Disease Management Update

Adis International Limited - In: Disease Management and Health Outcomes 11 (2003) 4, pp. 271-276

The rapid expansion of disease management continues. A multitude of stakeholders and marketplaces are now involved in providing cost-effective quality healthcare for individuals and populations. To help you keep up-to-date with the very latest developments in disease management, this section of...

Persistent link: https://www.econbiz.de/10005404612

Impact of Insurance Coverage on the Use and Effects of Smoking Cessation Medications

Solberg, Leif I. - In: Disease Management and Health Outcomes 13 (2005) 3, pp. 151-158

Tobacco use is not only the chief preventable cause of death, but it is also a very important contributor to the cause or complications of most chronic diseases. Therefore, facilitating smoking cessation should be very important to more effective disease management. Well-accepted, evidence-based...

Persistent link: https://www.econbiz.de/10005404613

The Approaches to Schizophrenia Communication (ASC) Tool: Including the Patient Perspective in Treatment

Dassori, Albana M.; Miller, Alexander L.; Weiden, Peter J. - In: Disease Management and Health Outcomes 11 (2003) 11, pp. 699-708

Adverse effects of antipsychotics are important determinants of patient attitudes towards medications, adherence to treatment, and quality of life. A discussion of adverse effects is therefore a crucial element of treatment and offers a unique opportunity for dialogue between the patient and the...

Persistent link: https://www.econbiz.de/10005404614

Acknowledgment

Adis International Limited - In: Disease Management and Health Outcomes 16 (2008) 6, pp. 375-376

DOI: 10.2165/0115677-200816060-00001

Persistent link: https://www.econbiz.de/10005404615

Disease Management of the Frail Elderly Population

Levine, Stuart; Reyes, Judy Y.; Schwartz, Randy; … - In: Disease Management and Health Outcomes 14 (2006) 4, pp. 235-243

Success stories of disease management programs have heightened the interest of healthcare payors and providers in the adoption of disease management principles for their aging members. However, caution is needed for rapid adoption, as several crucial characteristics within the aging population...

Persistent link: https://www.econbiz.de/10005404616

Developing a Specialist Patient Program for Migraine

Turner, Ann - In: Disease Management and Health Outcomes 14 (2006) 4, pp. 215-221

This review outlines a migraine-specific specialist patient program developed by the UK Migraine Action Association (MAA) for delivery to groups of patients with migraine throughout England and Wales. The program, which began in 2004, will deliver courses to 36 groups of 20 patients over 3...

Persistent link: https://www.econbiz.de/10005404617

Treatment of Pneumonias in a Managed-Care Organisation: The Impact of a Treatment Guideline Promotion on Physician Prescribing Behaviour

Armstrong, Edward P.; Langley, Paul C. - In: Disease Management and Health Outcomes 6 (1999) 3, pp. 159-173

prescribing by physicians. A relational database was created to measure changes in healthcare resources, use of antibacterials and …

Persistent link: https://www.econbiz.de/10005404618